Evidence map›Paper›PMID 36246175›Full record

ArticleOphthalmology science2022

A Novel Mutation in

Zhenbao Zhou, Liying Zhao, Yanqin Guo, Jingyi Zhuang, Nan Zhuo, Han Chen, Jieting Liu, Libo Wang

Open access · goldAbstract read
In one paragraph

Article in Ophthalmology science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. NovelInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhenbao ZhouDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Liying ZhaoDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Yanqin GuoDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Jingyi ZhuangDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Nan ZhuoDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Han ChenDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Jieting LiuDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Libo WangDepartment of Ophthalmology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Mudanjiang Medical University · CNFirst Affiliated Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Crystallin protein mutations are associated with congenital cataract (CC), and several disease-causing mutations in the Design: Observational study. Participants: A Chinese family diagnosed with autosomal dominant (AD) CCs with or without microphthalmia. Methods: Because this was an observational study, it was not registered as a clinical trial. The proband and her 2 children were diagnosed with AD CCs and microcornea and were recruited for the study. Participants underwent complete ophthalmological examinations, and blood samples were used for genomic extraction. Main Outcome Measures: We detected 1 disease-associated variant using Exomiser analysis by matching the proband's phenotype and the inheritance pattern. The variant was determined to be pathogenic according to American College of Medical Genetics and Genomics (ACMG) guidelines. Results: We detected 1 disease-associated variant using Exomiser analysis by matching the proband's phenotype and the inheritance pattern. The variant was determined to be pathogenic according to the American College of Medical Genetics and Genomics guidelines. Next-generation sequencing was verified using Sanger sequencing, and we confirmed that the proband and her children carried the same mutation. We identified the heterozygous variant c.389_390insGCTG (p.C130fs), which includes a frameshift mutation. The residues in p.C130fs are all highly conserved across species. This disease-causing frameshift mutation in the Conclusions: Our findings expand the repertoire of known mutations in the

Indexed as

ACMG, American College of Medical Genetics and GenomicsAD, autosomal dominantCC, congenital cataractCongenital cataractsCRYGC geneMicrocorneaNovel mutation

Identifiers

PMID36246175
PMCPMC9560566
OpenAlexW4200313009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.